Clear Street Derivatives »

Aspire Biopharma Hldgs Inc Wt Exp 021430 shares owned by Clear Street Derivatives

Quarter-by-quarter ownership of Aspire Biopharma Hldgs Inc Wt Exp 021430 (ASBPW) shares owned by Clear Street Derivatives from 13F filings

Historical chart of Clear Street Derivatives investment in Aspire Biopharma Hldgs Inc Wt Exp 021430

Tip: Access up to 7 years of quarterly data

All positions including Aspire Biopharma Hldgs Inc Wt Exp 021430 held by Clear Street Derivatives consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aspire Biopharma Hldgs Inc Wt Exp 021430 by Clear Street Derivatives

Quarter filed Position value Share count Share price at filing
2025-06-30 $4.7M 106k 44.70
2025-03-31 $7.2k 106k 0.07

More positions owned by Clear Street Derivatives

Mach Natural Resources Com Unit Ltd Par (MNR)
Txo Partners Com Unit (TXO)
Blaize Hldgs *w Exp 01/13/203 (BZAIW)
Murano Global Invts *w Exp 03/19/202 (MRNOW)
Complete Solaria *w Exp 07/31/202 (SPWRW)
Cxapp *w Exp 99/99/999 (CXAIW)
Spectral Ai *w Exp 99/99/999 (MDAIW)
Gcl Global Hldgs *w Exp 02/13/203 (GCLWW)
Veea *w Exp 09/13/202 (VEEAW)
Bridger Aerospace Grp Hldgs *w Exp 01/24/202 (BAERW)
Australian Oilseeds Hldgs Lt SHS (COOT)
Real Messenger Corp. *w Exp 11/19/202 (RMSGW)
Apollomics *w Exp 04/01/202 (APLMW)
Namib Minerals *w Exp 06/05/203 (NAMMW)
Able View Global *w Exp 08/18/202 (ABLVW)

View all positions for Clear Street Derivatives

Top funds holding Aspire Biopharma Hldgs Inc Wt Exp 021430

Adage Capital Partners GP
Saba Capital Management
Linden Advisors
Aristeia Capital
Highbridge Capital Management
Toronto-Dominion Bank
OZ Management
Verition Fund Management
Barclays
Clear Street
Millennium Management
Alberta Investment Management Corporation
Antara Capital
D. E. Shaw & Co
Wolverine Asset Management

View all funds holding Aspire Biopharma Hldgs Inc Wt Exp 021430